← Back to Search

Multidimensional Intervention for Opioid Use Disorder

N/A
Recruiting
Led By Charles Neighbors, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient inclusion will include anyone aged 18 or older who has been receiving take-home methadone for at least 30 days.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention (from baseline up to month 30), post-intervention (from month 6 up to month 36)
Awards & highlights

Study Summary

This trial will test if an intervention can help opioid treatment programs provide better care, reduce confusion and legal concerns, and reduce financial barriers to take-home dosing.

Who is the study for?
This trial is for staff at selected opioid treatment programs and patients aged 18 or older who have been on take-home methadone for over 30 days. It's open to all genders but excludes children, as the treatment system being studied mainly serves adults.Check my eligibility
What is being tested?
The study tests a clinic-level intervention in opioid treatment programs to see if it improves decision making and reduces barriers to methadone take-home dosing compared to usual care, using a stepped-wedge randomized controlled design.See study design
What are the potential side effects?
Since this trial focuses on improving service delivery rather than testing new medications, it does not directly involve side effects of drugs. However, changes in service may affect patient experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older and have been taking methadone at home for at least 30 days.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention (from baseline up to month 30), post-intervention (from month 6 up to month 36)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-intervention (from baseline up to month 30), post-intervention (from month 6 up to month 36) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in 14-Day THD Prescriptions
Change from Baseline in 28-Day THD Prescriptions
Change from Baseline in 7-Day THD Prescriptions
+4 more

Trial Design

6Treatment groups
Experimental Treatment
Group I: Cohort 6Experimental Treatment1 Intervention
6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in Cohort 5. Cohort 5 will start the six-month intervention at Month 30 and end at Month 36.
Group II: Cohort 5Experimental Treatment1 Intervention
6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in Cohort 5. Cohort 5 will start the six-month intervention at Month 24 and end at Month 30.
Group III: Cohort 4Experimental Treatment1 Intervention
6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in Cohort 4. Cohort 4 will start the six-month intervention at Month 18 and end at Month 24.
Group IV: Cohort 3Experimental Treatment1 Intervention
6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in Cohort 3. Cohort 3 will start the six-month intervention at Month 12 and end at Month 18.
Group V: Cohort 2Experimental Treatment1 Intervention
6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in Cohort 2. Cohort 2 will start the six-month intervention at Month 6 and end at Month 12.
Group VI: Cohort 1Experimental Treatment1 Intervention
6 of the 36 recruited opioid treatment programs (OTPs) will be enrolled in group 1. Group 1 will start the six-month intervention at Baseline and end at Month 6.

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,685 Previous Clinical Trials
6,930,478 Total Patients Enrolled
NYU Langone HealthLead Sponsor
1,363 Previous Clinical Trials
816,098 Total Patients Enrolled
Charles Neighbors, PhDPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
7,950 Total Patients Enrolled

Media Library

Clinic-Level Multidimensional Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05675735 — N/A
Social Environment Issues Research Study Groups: Cohort 6, Cohort 1, Cohort 5, Cohort 4, Cohort 3, Cohort 2
Social Environment Issues Clinical Trial 2023: Clinic-Level Multidimensional Intervention Highlights & Side Effects. Trial Name: NCT05675735 — N/A
Clinic-Level Multidimensional Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05675735 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment currently accepting volunteers?

"Data accessible on clinicaltrials.gov suggests that this particular medical trial is no longer enrolling patients, despite having been originally posted in January of 2023 and updated as recently as December 29th 2022. Nonetheless, there are 292 other studies actively looking for participants at the moment."

Answered by AI
~212 spots leftby Aug 2026